 |
Heart drug wins FDA approvalAstraZeneca announced that the US Food and Drug Administration (FDA) has approved ticagrelor (Brilinta), a new heart disease medication, to reduce the risk of cardiovascular death and heart attacks in patients with acute coronary syndromes (ACS).& More… |
Tuesday 24 December 2024
